Fate Therapeutics, Inc. (FATE) Revenue History
Fate Therapeutics, Inc. (FATE) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2016-12-31 | $4.40M |
| 2017-12-31 | $4.11M |
| 2018-12-31 | $4.74M |
| 2019-12-31 | $10.68M |
| 2020-12-31 | $31.43M |
| 2021-12-31 | $55.85M |
| 2022-12-31 | $96.30M |
| 2023-12-31 | $63.53M |
| 2024-12-31 | $13.63M |
| 2025-12-31 | $6.65M |
How FATE compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| NMTC | NeuroOne Medical Technologies Corporation | $9.10M |
| ACRS | Aclaris Therapeutics Inc. | $7.83M |
| ACHV | Achieve Life Sciences Inc. | $5.06M |
| XBIT | XBiotech Inc. | $4.01M |
| DYAI | Dyadic International Inc. | $3.09M |
These are five companies in the same sector as FATE with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Fate Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("FATE", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | FATE | $2.57 | +0.00% | 2.37M |
| 3 | ||||
| 4 | ||||
| 5 |